Optiscan Imaging Limited (OIL.XA)
Cboe AU · AUD
A$0.155 (+3.33%) as of
Key statistics
- EPS (TTM)
- -0.0050
- 52-week range
- 0.0800 – 0.1950
- Beta
- 0.15
- Revenue (TTM)
- 3.61M
- Profit margin
- -193.34%
- Volume
- 30.57k
About Optiscan Imaging Limited
Optiscan Imaging Limited engages in the development, manufacture, and commercialisation of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research. The company also provides InSpecta, a novel digital microscopic imaging device for veterinary medicine. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
- Headquarters
- Mulgrave, VIC, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.